Ionis Pharmaceuticals Stock Probability of Future Stock Price Finishing Over 46.55
| IONS Stock | USD 41.59 0.25 0.60% |
Closest to current price Ionis long CALL Option Payoff at Expiration
Ionis |
Ionis Pharmaceuticals Target Price Odds to finish over 46.55
The tendency of Ionis Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 46.55 or more in 90 days |
| 41.59 | 90 days | 46.55 | about 32.8 |
Based on a normal probability distribution, the odds of Ionis Pharmaceuticals to move over $ 46.55 or more in 90 days from now is about 32.8 (This Ionis Pharmaceuticals probability density function shows the probability of Ionis Stock to fall within a particular range of prices over 90 days) . Probability of Ionis Pharmaceuticals price to stay between its current price of $ 41.59 and $ 46.55 at the end of the 90-day period is about 51.75 .
Given the investment horizon of 90 days Ionis Pharmaceuticals has a beta of 0.66. This usually indicates as returns on the market go up, Ionis Pharmaceuticals average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Ionis Pharmaceuticals will be expected to be much smaller as well. Additionally Ionis Pharmaceuticals has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite. Ionis Pharmaceuticals Price Density |
| Price |
Predictive Modules for Ionis Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Ionis Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Ionis Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Ionis Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Ionis Pharmaceuticals is not an exception. The market had few large corrections towards the Ionis Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Ionis Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Ionis Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over NYSE Composite | -0.34 | |
β | Beta against NYSE Composite | 0.66 | |
σ | Overall volatility | 3.39 | |
Ir | Information ratio | -0.21 |
Ionis Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Ionis Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Ionis Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Ionis Pharmaceuticals generated a negative expected return over the last 90 days | |
| The company reported the previous year's revenue of 787.65 M. Net Loss for the year was (366.29 M) with loss before overhead, payroll, taxes, and interest of (257.87 M). | |
| Ionis Pharmaceuticals currently holds about 2.04 B in cash with (307.51 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 14.36. | |
| Over 99.0% of the company shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: Disposition of 4006 shares by Baroldi Joseph of Ionis Pharmaceuticals at 41.5978 subject to Rule 16b-3 |
Ionis Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Ionis Stock often depends not only on the future outlook of the current and potential Ionis Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Ionis Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 143.2 M | |
| Cash And Short Term Investments | 2.3 B |
Ionis Pharmaceuticals Technical Analysis
Ionis Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Ionis Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Ionis Pharmaceuticals. In general, you should focus on analyzing Ionis Stock price patterns and their correlations with different microeconomic environments and drivers.
Ionis Pharmaceuticals Predictive Forecast Models
Ionis Pharmaceuticals' time-series forecasting models is one of many Ionis Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Ionis Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Ionis Pharmaceuticals
Checking the ongoing alerts about Ionis Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Ionis Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Ionis Pharmaceuticals generated a negative expected return over the last 90 days | |
| The company reported the previous year's revenue of 787.65 M. Net Loss for the year was (366.29 M) with loss before overhead, payroll, taxes, and interest of (257.87 M). | |
| Ionis Pharmaceuticals currently holds about 2.04 B in cash with (307.51 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 14.36. | |
| Over 99.0% of the company shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: Disposition of 4006 shares by Baroldi Joseph of Ionis Pharmaceuticals at 41.5978 subject to Rule 16b-3 |
Check out Ionis Pharmaceuticals Backtesting, Ionis Pharmaceuticals Valuation, Ionis Pharmaceuticals Correlation, Ionis Pharmaceuticals Hype Analysis, Ionis Pharmaceuticals Volatility, Ionis Pharmaceuticals History as well as Ionis Pharmaceuticals Performance. For more information on how to buy Ionis Stock please use our How to Invest in Ionis Pharmaceuticals guide.You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Complementary Tools for Ionis Stock analysis
When running Ionis Pharmaceuticals' price analysis, check to measure Ionis Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ionis Pharmaceuticals is operating at the current time. Most of Ionis Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Ionis Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ionis Pharmaceuticals' price. Additionally, you may evaluate how the addition of Ionis Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |
Is Ionis Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ionis Pharmaceuticals. If investors know Ionis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ionis Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.44) | Earnings Share (2.56) | Revenue Per Share 5.501 | Quarterly Revenue Growth 1.136 | Return On Assets (0.08) |
The market value of Ionis Pharmaceuticals is measured differently than its book value, which is the value of Ionis that is recorded on the company's balance sheet. Investors also form their own opinion of Ionis Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Ionis Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ionis Pharmaceuticals' market value can be influenced by many factors that don't directly affect Ionis Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ionis Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ionis Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ionis Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.